Enanta Pharmaceuticals
ENTA
#7974
Rank
A$0.53 B
Marketcap
A$18.30
Share price
-1.31%
Change (1 day)
49.70%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of March 2026 : A$0.16 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has A$0.16 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$A$97.89 M-47.44%
2024-09-30$A$0.18 B-44.76%
2023-09-30$A$0.33 B-32.51%
2022-09-30$A$0.49 B-9.56%
2021-09-30$A$0.55 B-13.11%
2020-09-30$A$0.63 B-7.18%
2019-09-30$A$0.68 B25.67%
2018-09-30$A$0.54 B41.73%
2017-09-30$A$0.38 B8.8%
2016-09-30$A$0.35 B4.91%
2015-09-30$A$0.33 B98.01%
2014-09-30$A$0.17 B43.55%
2013-09-30$A$0.11 B179.39%
2012-09-30$A$42.42 M88.24%
2011-09-30$A$22.53 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$116.25 B 69,535.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$55.74 B 33,288.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-A$9.47 Billion-5,771.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$27.72 B 16,507.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$65.77 B 39,296.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.78 B 17,142.06%๐Ÿ‡บ๐Ÿ‡ธ USA